ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸

KROS // Keros Therapeutics Inc.

DIV <GO> NASDAQ RQD COCKPIT → CIK 0001664710 ↗
Health Care • Biotechnology: Pharmaceutical Preparations
$11.04 ▼ -0.32 (-2.82%)
MKT CAP: $225.2M • VOL: 120.2K
CASH DIVIDEND YIELD
0.00%
ANNUAL RATE: $0.00 / SH
TOTAL SHAREHOLDER YIELD
1.85%
BUYBACK YIELD: 1.85%
FCF PAYOUT COVERAGE RATIO
0.0%
GAAP EPS PAYOUT: 0.0%
DIVIDEND SAFETY SCORE NO DIVIDEND
50/100
GROWTH STREAK: 0 CONSECUTIVE YRS
KROS // EX-DIVIDEND & CAPITAL DISTRIBUTION SCHEDULE (DIV <GO>) SPOT: $11.04
Keros Therapeutics Inc. (KROS) DOES NOT CURRENTLY DISTRIBUTE A REGULAR CASH DIVIDEND. CAPITAL ALLOCATION PRIORITIZES INTERNAL R&D (85.0% ROIC) AND OPPORTUNISTIC SHARE REPURCHASES (1.85% BUYBACK YIELD).